Cytokinetics's market cap is currently $5.36B. The company's EPS TTM is $-5.388; its P/E ratio is ―; Cytokinetics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-1.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 7.53M	$ 94.59M	$ 70.43M	$ 55.83M	$ 26.87M
Gross Profit	$ -322.59M	$ -146.22M	$ -89.51M	$ -41.12M	$ -59.26M
Operating Income	$ -496.20M	$ -324.20M	$ -186.31M	$ -93.94M	$ -98.87M
EBITDA	$ -456.68M	$ -329.40M	$ -176.34M	$ -86.78M	$ -93.04M
Net Income	$ -526.24M	$ -402.55M	$ -242.37M	$ -164.13M	$ -149.05M
Balance Sheet
Cash & Short-Term Investments	$ 614.82M	$ 782.58M	$ 471.64M	$ 464.06M	$ 225.11M
Total Assets	$ 824.32M	$ 1.01B	$ 841.32M	$ 533.80M	$ 289.81M
Total Debt	$ 755.77M	$ 749.34M	$ 269.93M	$ 138.94M	$ 136.07M
Net Debt	$ 642.75M	$ 683.76M	$ 157.26M	$ 55.95M	$ 99.64M
Total Liabilities	$ 1.21B	$ 1.12B	$ 597.46M	$ 420.42M	$ 300.75M
Stockholders' Equity	$ -386.32M	$ -107.90M	$ 243.86M	$ 113.38M	$ -10.94M
Cash Flow
Free Cash Flow	$ -415.75M	$ -310.85M	$ -191.39M	$ -2.11M	$ -93.53M
Operating Cash Flow	$ -414.33M	$ -299.52M	$ -142.52M	$ 8.94M	$ -90.91M
Investing Cash Flow	$ 239.25M	$ -262.13M	$ -147.78M	$ -196.51M	$ -74.71M
Financing Cash Flow	$ 221.32M	$ 516.17M	$ 319.98M	$ 234.12M	$ 159.79M

Currency in USD

Cytokinetics Earnings and Revenue History

Income Statement >

Cytokinetics Debt to Assets

Balance Sheet >

Cytokinetics Cash Flow

Cash Flow >

Cytokinetics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing